Popular Articles

Juggling Cells Using High-Precision Laser Tweezers
Researchers at the University of Gothenburg, Sweden, have developed a new method to study single cells while exposing them to controlled environmental changes. The unique method, where a set of laser tweezers move the cell around in a microscopic channel system, allows the researchers to study how single cells react to stress induced by a constantly changing environment.

Extreme Sports Not About Risk-taking: Study
Those who think extreme sports are all about risk-taking are missing the point, according to a QUT researcher. Eric Brymer, a lecturer from the School of Human Movement Studies in the Faculty of Health, has been researching whether the element of risk was an important factor among participants in "extreme" sports such as waterfall kayakers, mountain climbers, big wave surfers and B.A.S.E. jumpers.
News of the day
Devax Receives IDE Approval To Commence DIVERGE II
Devax, Inc. announced that the U.S. Food and Drug Administration has conditionally approved an Investigational Device Exemption ("IDE") for its AXXESS™ Biolimus A9® Eluting Bifurcation Stent System (AXXESS System), allowing the company to initiate a pivotal clinical trial (DIVERGE II) of the device in the United States.
Sexual Health

Philips Introduces Three New Products To Improve Performance And Patient Comfort For Hospital And Home Ventilation

Royal Philips Electronics (NYSE: PHG, AEX: PHI) introduced three new respiratory support devices: the Respironics V60 and V200, and Trilogy100 ventilators. These ventilation solutions are intended to support breathing in the intensive care, sub-acute, and home care settings. As a family of products, the three devices are well-suited to address the ventilation care challenges that clinicians face on a daily basis, such as treating respiratory failure from exacerbations of chronic obstructive pulmonary disease (COPD) while avoiding ventilator-associated pneumonia. Respironics V60 Ventilator Following its acquisition of Respironics, Philips extends its recognized leadership in noninvasive ventilation (NIV) with the Respironics V60 Ventilator. It provides traditional invasive respiratory support with a tube inserted into the patient"s windpipe or noninvasive support via a patient face mask. "Noninvasive ventilation has been proven to significantly reduce the incidence of ventilator-associated pneumonia (VAP), and it has also been shown to shorten the time patients spend in the hospital," says Randy Whitfield, general manager of Hospital Respiratory Care, for Philips Healthcare. Respironics V200 Critical Care Ventilator The Respironics V200 Critical Care Ventilator, scheduled for release in June 2009, integrates auto-adaptive technology and provides ventilation for neonatal, pediatric and adult patients. The innovative speaking mode, found on only the Respironics V200 and Esprit ventilators, provides the tracheostomized patient the ability to speak without the need for costly external valves. Ryan Zumalt, director of Respiratory Care at Northern California Rehab Hospital, says, "The speaking mode really boosts the confidence of the patient, making them more apt to progress through the day and work with physical therapy, nursing, and respiratory therapy." Trilogy100 Ventilator Trilogy100 is a highly-versatile, lightweight (11 lbs.) life-support ventilator that meets the needs of a wide range of patients in the home and alternative care settings. Trilogy100 has many advanced features, such as auto-adaptive technology, volume- or pressure- control ventilation and the ability to ventilate with either a mask or a tracheal tube. "Trilogy100 has been designed to help caregivers and clinicians more easily administer care in the home and allow patients to be as active as possible while using the ventilator," says John Frank, vice president and general manager, Home Respiratory Care, for Philips Healthcare. "Its ease of use, versatility, and portability make Trilogy100 a significant advancement in home respiratory support." Royal Philips Electronics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):